-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Psoriasis is a chronic inflammatory skin disease that affects about 2.
5% of the population.
It has a long course of disease and a tendency to relapse.
Some cases will not heal for almost a lifetime
.
The incidence of this disease is mainly young and middle-aged, and it has a greater impact on the physical health and mental status of patients
Psoriasis is a chronic inflammatory skin disease .
5346 adult patients were identified from patient registries in Switzerland and Germany; 60% were men
.
Men are heavier than women (91 kg vs.
They followed up for one year after starting treatment, and women showed better improvement than men on the Psoriasis Area and Severity Index (PASI) and Dermatological Quality of Life Index (DLQI).
.
These results may reflect women’s better medication compliance, or their lower body weight-when men and women use the same dose, women’s dose per kilogram of body tissue will be higher
.
In addition, due to hormonal factors, women contain a higher proportion of fat, which may make it easier for the drug to spread in the body
These findings indicate that gender factors need to be taken into account in the treatment of psoriasis, and a more personalized treatment plan should be provided
Literature source: Maulet al.
Maulet al.
Do anti-psoriatic drugs work better in women than men? Br J Dermatol 2021 Dec;185(6) Br J Dermatol Br J Dermatol 2021 Dec;185(6) Leave a message here
